Gewählte Publikation:
Eller, P; Berjukov, S; Wanner, S; Huber, I; Hering, S; Knaus, HG; Toth, G; Kimball, SD; Striessnig, J.
High affinity interaction of mibefradil with voltage-gated calcium and sodium channels.
Br J Pharmacol. 2000; 130(3):669-677
Doi: 10.1038/sj.bjp.0703352
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Eller Philipp
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Mibefradil is a novel Ca(2+) antagonist which blocks both high-voltage activated and low voltage-activated Ca(2+) channels. Although L-type Ca(2+) channel block was demonstrated in functional experiments its molecular interaction with the channel has not yet been studied. We therefore investigated the binding of [(3)H]-mibefradil and a series of mibefradil analogues to L-type Ca(2+) channels in different tissues. [(3)H]-Mibefradil labelled a single class of high affinity sites on skeletal muscle L-type Ca(2+) channels (K(D) of 2.5+/-0.4 nM, B(max)=56.4+/-2.3 pmol mg(-1) of protein). Mibefradil (and a series of analogues) partially inhibited (+)-[(3)H]-isradipine binding to skeletal muscle membranes but stimulated binding to brain L-type Ca(2+) channels and alpha1C-subunits expressed in tsA201 cells indicating a tissue-specific, non-competitive interaction between the dihydropyridine and mibefradil binding domain. [(3)H]-Mibefradil also labelled a heterogenous population of high affinity sites in rabbit brain which was inhibited by a series of nonspecific Ca(2+) and Na(+)-channel blockers. Mibefradil and its analogue RO40-6040 had high affinity for neuronal voltage-gated Na(+)-channels as confirmed in binding (apparent K(i) values of 17 and 1.0 nM, respectively) and functional experiments (40% use-dependent inhibition of Na(+)-channel current by 1 microM mibefradil in GH3 cells). Our data demonstrate that mibefradil binds to voltage-gated L-type Ca(2+) channels with very high affinity and is also a potent blocker of voltage-gated neuronal Na(+)-channels. More lipophilic mibefradil analogues may possess neuroprotective properties like other nonselective Ca(2+)-/Na(+)-channel blockers.
- Find related publications in this database (using NLM MeSH Indexing)
-
Animals -
-
Calcium Channel Blockers - pharmacology
-
Calcium Channels, L-Type - drug effects
-
Electric Stimulation -
-
Electrophysiology -
-
Guinea Pigs -
-
Ion Channel Gating - drug effects
-
Mibefradil - pharmacology
-
Muscle, Skeletal - drug effects Muscle, Skeletal - metabolism
-
Patch-Clamp Techniques -
-
Rabbits -
-
Radioligand Assay -
-
Sodium Channel Blockers -
- Find related publications in this database (Keywords)
-
Ca2+ channel blockers
-
sodium channel blockers
-
mibefradil